[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100360815":3},{"organization":4,"outcomesModule":7,"designInfo":20,"detailedDescription":19,"studyPopulation":23,"armGroups":24,"interventions":34,"overallOfficials":54,"centralContacts":65,"locations":74,"responsibleParty":111,"collaborators":113,"id":116,"slug":19,"hasResults":117,"nctId":118,"briefTitle":119,"officialTitle":120,"acronym":121,"eligibilityCriteria":122,"healthyVolunteers":117,"sex":123,"minAge":19,"maxAge":19,"enrollmentInfo":124,"targetDuration":127,"studyType":128,"phases":19,"briefSummary":129,"conditions":130,"keywords":132,"overallStatus":77,"whyStopped":19,"lastUpdateSubmitDate":137,"lastUpdatePostDateStruct":138,"startDateStruct":141,"completionDateStruct":143,"leadSponsor":145,"locationsCount":146},{"fullName":5,"class":6},"Institut Bergonié","OTHER",{"primaryOutcomes":8,"secondaryOutcomes":19,"otherOutcomes":19},[9,13,15,18],{"measure":10,"description":11,"timeFrame":12},"Time to next treatment (TNT)","Time from the systemic treatment onset to the next treatment or death due to any cause, whichever comes first. When neither death nor new systemic therapy is observed, TNT is censored at the date of last patient contact.","2 years",{"measure":10,"description":11,"timeFrame":14},"5 years",{"measure":16,"description":17,"timeFrame":12},"Overall survival (OS)","Interval between diagnosis and the time of death. When death is not observed, OS is censored at the date of last patient contact.",{"measure":16,"description":17,"timeFrame":14},null,{"allocation":19,"interventionModel":19,"interventionModelDescription":19,"primaryPurpose":19,"observationalModel":21,"timePerspective":22,"maskingInfo":19},"COHORT","PROSPECTIVE","Diagnosis of sarcoma",[25],{"label":26,"type":19,"description":27,"interventionNames":28},"Patients with sarcoma","Patients with a sarcoma diagnosed in a French Comprehensive cancer Center",[29,30,31,32,33],"Drug: Chemotherapy","Drug: Immunotherapeutic Agent","Drug: target treatment","Procedure: Surgery","Radiation: Radiotherapy",[35,40,43,46,50],{"type":36,"name":37,"description":38,"armGroupLabels":39,"otherNames":19},"DRUG","Chemotherapy","treatment as per standard of care",[26],{"type":36,"name":41,"description":38,"armGroupLabels":42,"otherNames":19},"Immunotherapeutic Agent",[26],{"type":36,"name":44,"description":38,"armGroupLabels":45,"otherNames":19},"target treatment",[26],{"type":47,"name":48,"description":38,"armGroupLabels":49,"otherNames":19},"PROCEDURE","Surgery",[26],{"type":51,"name":52,"description":38,"armGroupLabels":53,"otherNames":19},"RADIATION","Radiotherapy",[26],[55,59,62],{"name":56,"affiliation":57,"role":58},"Maud Toulmonde, MD","Institut Bergonié, Bordeaux, France","STUDY_CHAIR",{"name":60,"affiliation":61,"role":58},"Axel Le Cesne, MD\u002FPhD","Institut Gustave Roussy, Villejuif, France",{"name":63,"affiliation":64,"role":58},"Jean-Yves Blay, MD\u002FPhD","Centre Léon Bérard, Lyon, France",[66,70],{"name":56,"role":67,"phone":68,"phoneExt":19,"email":69},"CONTACT","0556333333","m.toulmonde@bordeaux.unicancer.fr",{"name":71,"role":67,"phone":72,"phoneExt":19,"email":73},"Simone Mathoulin-Pélissier, MD\u002FPhD","05563333","s.mathoulin@bordeaux.unicancer.fr",[75,91,101],{"facility":76,"status":77,"city":78,"state":19,"zip":19,"country":79,"countryCode":80,"cosmosGeoPoint":81,"geoPoint":86,"contacts":87},"Institut Bergonié, Comprehensive Cancer Center","RECRUITING","Bordeaux","France","FR",{"type":82,"coordinates":83},"Point",[84,85],-0.58046,44.84124,{"lat":85,"lon":84},[88,89],{"name":56,"role":67,"phone":19,"phoneExt":19,"email":19},{"name":90,"role":67,"phone":19,"phoneExt":19,"email":19},"Antoine Italiano, MD\u002FPhD",{"facility":92,"status":77,"city":93,"state":19,"zip":19,"country":79,"countryCode":80,"cosmosGeoPoint":94,"geoPoint":98,"contacts":99},"Centre Léon Bérard","Lyon",{"type":82,"coordinates":95},[96,97],4.84789,45.74906,{"lat":97,"lon":96},[100],{"name":63,"role":67,"phone":19,"phoneExt":19,"email":19},{"facility":102,"status":77,"city":103,"state":19,"zip":19,"country":79,"countryCode":80,"cosmosGeoPoint":104,"geoPoint":108,"contacts":109},"Institut Gustave Roussy, Comprehensive Cancer Center","Villejuif",{"type":82,"coordinates":105},[106,107],2.35992,48.7939,{"lat":107,"lon":106},[110],{"name":60,"role":67,"phone":19,"phoneExt":19,"email":19},{"type":112,"investigatorFullName":19,"investigatorTitle":19,"investigatorAffiliation":19,"oldNameTitle":19,"oldOrganization":19},"SPONSOR",[114],{"name":115,"class":6},"French Sarcoma Group","100360815",false,"NCT03978039","National Clinical and Biological Sarcoma Database : An Initiative of the French Sarcoma Group","The \"BCB-sarcomes\" Database: the Database of the French Sarcoma Group Dedicated to the Collection of Clinical and Biological Data for All Sarcomas","BCB-Sarcomes","Inclusion criteria :\n\n* Diagnosis of sarcoma\n* Diagnosis in a French Comprehensive Cancer Center\n* Any age","ALL",{"count":125,"type":126},150000,"ESTIMATED","10 Years","OBSERVATIONAL","The BCB SARCOMES database is a clinical and biological national database dedicated to sarcoma that contains 3 main databases with specific aims: the first is the pathology database (French expert network dedicated to the management of bone sarcomas \\[RESOS\\] \u002F French expert network dedicated to the pathology of sarcomas \\[RREPS\\]), dedicated to systematic review of mesenchymal tumor diagnostics nationwide; the second is clinical (RESOS \u002F French expert clinical network for sarcomas \\[NETSARC\\]), collecting multidisciplinary tumor boards (MDTB) data of patients nationwide, and the third (CONTICABASE \u002F BONE \u002F GIST) is dedicated to collecting patients longitudinal\u002Ffollow up data, with a focus on treatments of every events, and a catalogue of associated samples.\n\nPrimary objectives of BCB-SARCOMES are the following: description of the patterns of care and treatment outcomes, assessment of the prognostic factors of patients' outcomes.\n\nWith the financial support of the French National Cancer Institute \\[Institut National du cancer \\[INCa\\]).",[131],"Sarcoma",[133,134,135,136],"patterns of care","access to care","survival","experts' network","2025-08-28",{"date":139,"type":140},"2025-09-04","ACTUAL",{"date":142,"type":140},"2010-01-01",{"date":144,"type":126},"2035-12-31",{"name":5,"class":6},3]